Age dependence of modern clinical risk groups for localized prostate cancer—A population‐based study

A genetic risk score to personalize prostate cancer screening, applied to population data.

(2019) Minh-Phuong Huynh-Le et al.   JOURNAL OF CLINICAL ONCOLOGY

Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004–2014

(2018) Jun Li et al.   ANNALS OF EPIDEMIOLOGY

A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts

(2018) Donna P. Ankerst et al.   EUROPEAN UROLOGY

Screening for Prostate Cancer

(2018) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer

(2018) Daniel E. Spratt et al.   JOURNAL OF CLINICAL ONCOLOGY

Radical Prostatectomy or Watchful Waiting in Prostate Cancer — 29-Year Follow-up

(2018) Anna Bill-Axelson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Biases in Recommendations for and Acceptance of Prostate Biopsy Significantly Affect Assessment of Prostate Cancer Risk Factors: Results From Two Large Randomized Clinical Trials

(2016) Catherine M. Tangen et al.   JOURNAL OF CLINICAL ONCOLOGY

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

(2016) Freddie C. Hamdy et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening

(2016) Andrew J. Vickers et al.   UROLOGY

Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2015) C. Parker et al.   ANNALS OF ONCOLOGY

Trends in stage-specific incidence of prostate cancer in Norway, 1980-2010: a population-based study

(2015) Mette H. Møller et al.   BJU INTERNATIONAL

Association Between Older Age and Increasing Gleason Score

(2015) Vinayak Muralidhar et al.   Clinical Genitourinary Cancer

Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer

(2014) Donna P. Ankerst et al.   UROLOGY

A New Risk Classification System for Therapeutic Decision Making with Intermediate-risk Prostate Cancer Patients Undergoing Dose-escalated External-beam Radiation Therapy

(2013) Zachary S. Zumsteg et al.   EUROPEAN UROLOGY

Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study

(2013) A. J. Vickers et al.   BMJ-British Medical Journal

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening

(2011) N Pashayan et al.   BRITISH JOURNAL OF CANCER

Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer

(2011) Christopher U. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE

NORDCAN – a Nordic tool for cancer information, planning, quality control and research

(2010) Gerda Engholm et al.   ACTA ONCOLOGICA

American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010

(2010) A. M. D. Wolf et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prostate cancer: Trends in incidence, survival and mortality in the Netherlands, 1989–2006

(2010) R.G.H.M. Cremers et al.   EUROPEAN JOURNAL OF CANCER

Contemporary Risk Profile of Prostate Cancer in the United States

(2009) Yu-Hsuan Shao et al.   JNCI-Journal of the National Cancer Institute

Duration of Androgen Suppression in the Treatment of Prostate Cancer

(2009) Michel Bolla et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness

(2008) Inger Kristin Larsen et al.   EUROPEAN JOURNAL OF CANCER